Research context and placement

It separates nonspecific drug loss at lubricated channels from necessary cell attachment on the culture membrane. As an in vitro organ model, its connection to device–host response is extended and remains ambiguous.

Boundary case: assigned to the closest interface for navigation. Read the rationale and cross-links together; the primary theme does not delimit the study. Placement of foundational work does not establish direct bioelectronic application.

Drug loss and cell-culture interfaces in organ-on-a-chip models

PDMS can absorb small molecules, changing the dose reaching cells in an organ chip. Making every surface nonadhesive would also complicate culture. This study separates the roles of drug-contacting channel walls and the cell-supporting substrate.

Approach and advances

Lubricated channel walls address nonspecific loss, while an ECM-coated semiporous PET membrane supports cells. The design assigns different attachment requirements to different regions. Uniform repellency across the entire chip would not serve both purposes.

A transparent channel with blue lubricated walls, cells on gold ECM above a porous-membrane symbol, solute symbols and a flow arrow.
AI-generated concept diagram · not an experimental image

AI-generated concept separating PreD’s lubricated channel walls from its ECM-coated PET cell-support membrane. Only one simplified channel is shown; this is not evidence of drug recovery, toxicity prediction or organ function.

The lower channel is omitted. Enlarged pores, thickness, ECM fibers, cells and solutes are symbols rather than actual pore architecture, morphology, concentration or flow fields. Gold does not signify metal.

This is not a reproduced paper figure and does not establish permission to reuse the original figure.

Generated in ChatGPT on the web from concepts in a public paper and checked for conceptual consistency within the selected main-text reading and stated independent-review scope. This does not claim a complete main-text or supplement audit. Display processing is limited to WebP encoding, without cropping or content editing.

Source paper ↗ · DOI: 10.1002/smll.202402431 ↗

Evaluation and conditions

Empty-chip fluorescence and drug recovery measure losses in the fluid pathway. Gut toxicity and blood–brain-barrier transport ask biological questions in cell-containing chips. Improved recovery alone cannot establish the clinical predictive validity of those models.

Key findings

The gut-model DEX concentration series reported a lower IC50 in PreD than in the conventional chip under matched flow and exposure. This connects reduced device loss with a changed cellular toxicity readout. It remains specific to the DEX/Caco-2 conditions, not validation of clinical toxicity prediction for every drug.

Limits and open questions

Comparisons need molecular properties, concentration, flow, exposure and cell/membrane conditions. Coating durability and broader drug recovery remain follow-up questions. The authors also require further clinical-predictivity validation; this is not an established clinical replacement test.

Related external research

PDMS absorption of small molecules and consequences in microfluidic applications

DOI: 10.1039/b612140c ↗

Toepke and Beebe identify concentration changes caused by PDMS partitioning; PreD addresses this through coating and culture-compartment design.

The external abstract establishes the problem, not uniform loss or coating benefit for every molecule.

Abstract checked

Corresponding-author verification

Jungmok Seo: corresponding author

This record concerns Jungmok Seo’s correspondence designation. Author order or an asterisk alone is not treated as confirmation; this check is separate from verification of the research content.

Main-text review scope
Read public Wiley text on drug recovery, gut/BBB models and conclusions. The authors explicitly require further validation of clinical predictive value.
Supplementary review scope
Supporting information was not comprehensively read. A main-text citation to supplementary results does not count as direct inspection of those results.
Pending verification
Verify the supplementary drug panel, oxygen-transport evidence and longer culture limits at school.

COVERAGE & OUTREACH

Coverage and outreach

Links are checked for their relationship to this paper. Media publication does not establish independent reporting or additional experimental validation.

  • Yonsei University Research Archive · Date unconfirmed · Institutional release

    Innovative PreD Chip for Drug Testing developed ↗

    The feature explicitly supplies the exact title and DOI 10.1002/smll.202402431 and identifies the Seo–Park PreD collaboration.

    Body read Read the feature body and Find out more citation. No feature publication date was visible; the paper date was not substituted.

  • 아시아타임즈 / Asia Times · 2024-07-04 · Release-based reporting / republication

    연세대, UNIST와 '약물 테스트 칩, PreD' 개발 ↗

    Seo, Kim, Park and Choi, Small, and PFPE-coated PDMS PreD technology match #81.

    Body read Read the body, byline and date. It explicitly attributes the announcement to Yonsei; no independent follow-up testing or outside-expert validation was established.

Channel coverage and search log for all 101 records →

Sources and verification scope

Read public Wiley text on drug recovery, gut/BBB models and conclusions. The authors explicitly require further validation of clinical predictive value.

The additional commentary is editorially approved within the stated evidence scope. This does not imply complete verification of all main-text and supplementary material.

Additional main-text review scope
Read public Wiley text on drug recovery, gut/BBB models and conclusions. The authors explicitly require further validation of clinical predictive value.
Additional supplementary review scope
Supporting information was not comprehensively read. A main-text citation to supplementary results does not count as direct inspection of those results.